S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Perceptive Advisors/Q3 2025

Perceptive Advisors

Period: Q3 2025 Β· Filed: 2025-11-14
View on SEC EDGAR β†—
AUM
$3.46B
Total portfolio value
Positions
92
Reported securities
Top Holding
RYTM
8.3% $288.4M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
RYTMRHYTHM PHARMACEUTICALS INC$288.4M8.33%$100.99$114.17+13.1%
8.3%
ASNDASCENDIS PHARMA A/S$216.4M6.25%$198.81$274.50+38.1%
6.3%
ACLXARCELLX INC$202.7M5.85%$82.10β€”
5.8%
CELCCELCUITY INC$146.0M4.22%$49.40$107.95+118.5%
4.2%
NUVLNUVALENT INC$135.1M3.90%$86.48$123.73+43.1%
3.9%
MRUSMERUS N V$127.4M3.68%β€”β€”
3.7%
AMLXAMYLYX PHARMACEUTICALS INC$121.7M3.51%$13.59$18.27+34.4%
3.5%
ROIVROIVANT SCIENCES LTD$111.5M3.22%$15.13$35.13+132.2%
3.2%
MGTXMEIRAGTX HLDGS PLC$103.8M3.00%$8.23$13.92+69.1%
3.0%
INSMINSMED INC$101.1M2.92%$144.01$111.60-22.5%
2.9%
TVTXTRAVERE THERAPEUTICS INC$90.7M2.62%$23.90$56.92+138.2%
2.6%
AORTARTIVION INC$85.5M2.47%$42.34$23.97-43.4%
2.5%
PRAXPRAXIS PRECISION MEDICINES I$82.9M2.39%$53.00$318.52+501.0%
2.4%
IMTXIMMATICS N.V$80.0M2.31%$8.52$9.95+16.8%
2.3%
CNTACENTESSA PHARMACEUTICALS PLC$75.2M2.17%$24.25$40.50+67.0%
2.2%
SLDBSOLID BIOSCIENCES INC$73.0M2.11%$6.17$10.84+75.7%
2.1%
PTGXPROTAGONIST THERAPEUTICS INC$68.4M1.98%$66.43$131.62+98.1%
2.0%
NBIXNEUROCRINE BIOSCIENCES INC$63.2M1.82%$140.38$174.26+24.1%
1.8%
EWTXEDGEWISE THERAPEUTICS INC$61.6M1.78%$16.22$39.56+143.9%
1.8%
VRNAVERONA PHARMA PLC$55.9M1.61%β€”β€”
1.6%
PENPENUMBRA INC$55.9M1.61%$253.32$318.57+25.8%
1.6%
AKROAKERO THERAPEUTICS INC$53.9M1.56%β€”β€”
1.6%
APGEAPOGEE THERAPEUTICS INC$53.7M1.55%$39.73$132.91+234.5%
1.6%
OMDAOMADA HEALTH INC$53.0M1.53%$22.11$22.39+1.3%
1.5%
FOLDAMICUS THERAPEUTICS INC$50.2M1.45%β€”β€”
1.4%
ATXSASTRIA THERAPEUTICS INC$47.2M1.36%β€”β€”
1.4%
INBXINHIBRX BIOSCIENCES INC$44.7M1.29%$33.68$97.58+189.7%
1.3%
RGENREPLIGEN CORP$36.1M1.04%$133.67$142.40+6.5%
1.0%
ZYMEZYMEWORKS INC$35.7M1.03%$17.08$26.31+54.0%
1.0%
SIONSIONNA THERAPEUTICS INC$34.7M1.00%$29.41$43.99+49.6%
1.0%

Quarter-on-Quarter Activity

Q3 2025 vs. Q2 2025

New Positions (8)

TickerIssuerNotional
ABVXABIVAX SA$33.0M
EXASEXACT SCIENCES CORP$25.5M
PVLAPALVELLA THERAPEUTICS INC NE$24.8M
ORKAORUKA THERAPEUTICS INC$24.4M
IRTCIRHYTHM TECHNOLOGIES INC$21.1M
ENGNENGENE HOLDINGS INC$14.3M
RAPPRAPPORT THERAPEUTICS INC$12.0M
KODKODIAK SCIENCES INC$10.4M

Exited Positions (8)

TickerIssuerNotional
SLNOSOLENO THERAPEUTICS INC$36.1M
XBISPDR SERIES TRUST$24.9M
EOLSEVOLUS INC$22.8M
PODDINSULET CORP$19.0M
CRLCHARLES RIV LABS INTL INC$15.2M
RAREULTRAGENYX PHARMACEUTICAL IN$9.8M
CAPRCAPRICOR THERAPEUTICS INC$6.5M
GMEDGLOBUS MED INC$5.2M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
RYTMRHYTHM PHARMACEUTICALS INC$135.6M+17230.6%+13.1%
PENPENUMBRA INC$47.5M+572.5%+25.8%
TVTXTRAVERE THERAPEUTICS INC$78.3M+354.9%+138.2%
VRDNVIRIDIAN THERAPEUTICS INC$25.3M+226.8%
CNTACENTESSA PHARMACEUTICALS PLC$60.1M+170.4%+67.0%
ROIVROIVANT SCIENCES LTD$73.9M+121.2%+132.2%
PRAXPRAXIS PRECISION MEDICINES I$51.3M+107.8%+501.0%
MRUSMERUS N V$90.1M+91.1%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
VRNAVERONA PHARMA PLC$-465.0M-90.5%
BBNXBETA BIONICS INC$-17.7M-82.6%
DYNDYNE THERAPEUTICS INC$-14.6M-76.0%
VKTXVIKING THERAPEUTICS INC$-7.3M-72.3%
AORTARTIVION INC$-1.4M-27.7%-43.4%
IMVTIMMUNOVANT INC$-8.6M-25.7%
AXSMAXSOME THERAPEUTICS INC$-2.6M-25.0%
SYRESPYRE THERAPEUTICS INC$-2.3M-19.6%
← Back to Hedge Funds